Inventor
Dror Harats
Inventor
Ramat Gan, IL
Overview
Patents· 31 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C12NMicroorganisms or enzymes11%
B82YSpecific uses or applications of nanostructures8%
C07CAcyclic or carbocyclic compounds8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
Y02ATechnologies for adaptation to climate change8%
C07KPeptides7%
C07HSugars2%
A01KAnimal husbandry2%
PatentTitleYear
9,180,152'Method for treating psoriasis'20158,961,993'Method of treating retinitis pigmentosa'20158,916,378'Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy'20148,859,745'Promoters exhibiting endothelial cell specificity and methods of using same'20148,859,747'Promoters exhibiting endothelial cell specificity and methods of using same'20148,846,401'Promoters exhibiting endothelial cell specificity and methods of using same'20148,835,398'Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis'20148,563,534'Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis'20138,529,907'Methods of treating ophthalmic disorders'20138,501,715'Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders'20138,415,318'Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy'20138,343,549'Therapeutic uses of Dunaliella powder'20138,206,743'Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis'20128,158,611'Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis'20128,071,740'Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis'20118,039,261'Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis'20117,989,427'Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy'20117,973,023'Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders'20117,902,176'Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders'20117,893,291'Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis'20117,763,255'Therapeutic uses of Dunaliella powder'20107,625,882'Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders'20097,585,666'Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy'20097,579,327'Promoters exhibiting endothelial cell specificity and methods of using same'20097,504,388'Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis'20097,279,459'Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis'20077,264,813'Therapeutic uses of Dunaliella powder'20077,186,704'Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis'20077,067,649'Promoters exhibiting endothelial cell specificity and methods of using same'20066,838,452'Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis'20055,747,340'Targeted gene expression using preproendothelin-1 promoters'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2015Based in Ramat Gan, IL· patent location history
2005–2014Patents assigned to VASCULAR BIOGENICS LTD (24)· patent assignee history
2007–2015Patents assigned to TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD (6)· patent assignee history
2011–2015Patents assigned to HARATS DROR (12)· patent assignee history
2011–2014Patents assigned to BREITBART EYAL (6)· patent assignee history
2011–2015Patents assigned to GREENBERGER SHOSHANA (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VASCULAR BIOGENICS LTD | 24 | 2005–2014 |
| HARATS DRORself | 12 | 2011–2015 |
| BREITBART EYAL | 6 | 2011–2014 |
| TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD | 6 | 2007–2015 |
| GREENBERGER SHOSHANA | 5 | 2011–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ramat Gan, IL | 31 | 1998–2015 |